First, small molecular compounds can be developed to disrupt the binding of DEPTOR to ErbB2, as small molecule inhibitors of DEPTOR-mTOR interaction have been shown to be cytotoxic against multiple myeloma cells 32, 33. The gene discussed is ERBB2; the disease is plasma cell myeloma.